These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27219102)

  • 21. Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.
    Tröbs M; Achenbach S; Röther J; Klinghammer L; Schlundt C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):872-880. PubMed ID: 27142643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effect of side branch intervention on long-term clinical outcomes according to side branch stenosis after main vessel stenting: Results from the COBIS (Coronary Bifurcation Stenting) Registry II.
    Jang WJ; Park YH; Hahn JY; Song YB; Choi SH; Chun WJ; Hyeon Oh J; Koo BK; Rha SW; Jang Y; Tahk SJ; Kim HS; Gwon HC
    Int J Cardiol; 2016 Oct; 221():471-7. PubMed ID: 27414725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.
    Serruys PW; Ormiston J; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Chevalier B; Smits P; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Wasungu L; Ediebah D; Veldhof S; Onuma Y
    J Am Coll Cardiol; 2016 Feb; 67(7):766-76. PubMed ID: 26892411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
    Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D
    JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.
    Gutiérrez-Chico JL; Cortés C; Schincariol M; Limon U; Yalcinli M; Durán-Cortés MA; Jaguszewski M
    Cardiol J; 2018; 25(4):443-458. PubMed ID: 29774520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of bioresorbable vascular scaffolds in acute coronary syndrome: A two-center, one-year follow-up analysis.
    Iwańczyk S; Hiczkiewicz J; Araszkiewicz A; Łanocha M; Adamczak D; Faron W; Grajek S; Lesiak M
    Cardiol J; 2018; 25(4):479-486. PubMed ID: 29168541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry.
    Imori Y; D'Ascenzo F; Gori T; Münzel T; Fabrizio U; Campo G; Cerrato E; Napp LC; Iannaccone M; Ghadri JR; Kazemian E; Binder RK; Jaguszewski M; Csordas A; Capasso P; Biscaglia S; Conrotto F; Varbella F; Garbo R; Gaita F; Erne P; Lüscher TF; Moretti C; Frangieh AH; Templin C
    Cardiol J; 2016; 23(4):374-83. PubMed ID: 27515481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis.
    Kim YH; Lee JH; Roh JH; Ahn JM; Yoon SH; Park DW; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Seung KB; Shin WY; Lee NH; Lee BK; Lee SG; Nam CW; Yoon J; Yang JY; Hyon MS; Lee K; Jang JS; Kim HS; Park SW; Park SJ
    JACC Cardiovasc Interv; 2015 Apr; 8(4):550-60. PubMed ID: 25907082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
    Kervinen K; Niemelä M; Romppanen H; Erglis A; Kumsars I; Maeng M; Holm NR; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Helqvist S; Vikman S; Wiseth R; Aarøe J; Jokelainen J; Thuesen L;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1160-5. PubMed ID: 24262616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.
    Orvin K; Carrie D; Richardt G; Desmet W; Assali A; Werner G; Ikari Y; Fujii K; Goicolea J; Dangoisse V; Manari A; Saito S; Wijns W; Kornowski R
    Catheter Cardiovasc Interv; 2016 May; 87(6):1092-100. PubMed ID: 26268482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neointimal coverage of jailed side branches in coronary bifurcation lesions: an optical coherence tomography analysis.
    Kume T; Yamada R; Terumasa K; Tamada T; Imai K; Fukuhara K; Goryo Y; Kawamura A; Hiroshi O; Neishi Y; Uemura S
    Coron Artery Dis; 2018 Mar; 29(2):114-118. PubMed ID: 28926354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.
    Généreux P; Kumsars I; Lesiak M; Kini A; Fontos G; Slagboom T; Ungi I; Metzger DC; Wykrzykowska JJ; Stella PR; Bartorelli AL; Fearon WF; Lefèvre T; Feldman RL; LaSalle L; Francese DP; Onuma Y; Grundeken MJ; Garcia-Garcia HM; Laak LL; Cutlip DE; Kaplan AV; Serruys PW; Leon MB
    J Am Coll Cardiol; 2015 Feb; 65(6):533-43. PubMed ID: 25677311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and significance of side branch occlusions following bioresorbable scaffold implantation for long left anterior descending artery lesions.
    Tanaka A; Jabbour RJ; Kawamoto H; Chieffo A; Carlino M; Montorfano M; Latib A; Colombo A
    Int J Cardiol; 2016 Nov; 222():674-675. PubMed ID: 27526354
    [No Abstract]   [Full Text] [Related]  

  • 36. Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
    Barkholt TØ; Neghabat O; Holck EN; Andreasen LN; Christiansen EH; Holm NR
    Catheter Cardiovasc Interv; 2022 Mar; 99(4):1075-1083. PubMed ID: 34967094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preintervention angiographic and intravascular ultrasound predictors for side branch compromise after a single-stent crossover technique.
    Kang SJ; Mintz GS; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Am J Cardiol; 2011 Jun; 107(12):1787-93. PubMed ID: 21507367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorb everolimus-eluting bioresorbable scaffolds in coronary bifurcations: a bench study of deployment, side branch dilatation and post-dilatation strategies.
    Ormiston JA; Webber B; Ubod B; Webster MW; White J
    EuroIntervention; 2015 Feb; 10(10):1169-77. PubMed ID: 24835848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage of side branch by provisional "TAP technique" using Absorb™ bioresorbable vascular scaffolds for bifurcation lesions: first case reports with technical considerations.
    Seth A; Sengottuvelu G; Ravisekar V
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):55-61. PubMed ID: 24677764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.